IGF1 and breast carcinoma: In breast cancer cells, E-cadherin downregulation hyperactivates IGF1R/IR signaling, thus enhancing sensitivity of breast cancer cells to IGF1 stimulation and Akt or ERK phosphorylation [4,157].